{
  "image_filename": "figure_p1_det_0_017.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/figure_p1_det_0_017.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_017",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "First page of a clinical article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age,' showing author names and the beginning of the abstract. No specific vaccine brand names or trial comparators are visible. does not support the claim because the image does not name Flublok or Fluarix or explicitly describe a pivotal trial comparing these two vaccines. Note: Limited to the title and abstract heading; trial details and brand names may appear later but are not visible here.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "First page of a clinical article titled 'Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age,' showing author names and the beginning of the abstract. No specific vaccine brand names or trial comparators are visible.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image does not name Flublok or Fluarix or explicitly describe a pivotal trial comparing these two vaccines.",
    "confidence_notes": "Limited to the title and abstract heading; trial details and brand names may appear later but are not visible here."
  }
}